As the first oral GLP-1 approved for weight loss , the newly-approved Wegovy pill ( semaglutide ) is an exciting alternative for people who may be apprehensive about injections or would prefer an oral medication
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not a pure GLP-1 agent
According to researchers from the University of Pennsylvania and Cedars-Sinai Medical Center, the number of non-diabetic patients starting these medications jumped from 21,000 in 2019 to over 174,000 in 2023
Why MEDVi Is Different Many clinics offer Semaglutide or Tirzepatide, but few deliver the customized, multi-touch experience that MEDVi is known for
At Ledisa, we are committed to science-backed, ingredient-based wellness solutions that work in harmony with your body
The right amount for you depends on your unique physiology, medical history, and how your body responds